Dominik Lock
Bergisch Gladbach, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Mapping the clinical landscape of multifunctional CAR T cells: Targets, trends, and synergies.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 19, 2025
A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo.
Journal: Molecular therapy. Methods & clinical development
Published: September 19, 2024
CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment.
Journal: Molecular therapy. Oncology
Published: January 07, 2024
Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy.
Journal: Molecular therapy. Methods & clinical development
Published: November 30, 2023
Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice.
Journal: International journal of molecular sciences
Published: April 13, 2023
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma.
Journal: Frontiers in immunology
Published: March 02, 2023
Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR".
Journal: International journal of molecular sciences
Published: September 29, 2022
Automated, scaled, transposon-based production of CAR T cells.
Journal: Journal for immunotherapy of cancer
Published: August 23, 2022
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting.
Journal: Oncoimmunology
Published: June 10, 2022
Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors.
Journal: Cancers
Published: May 31, 2021
Automated generation of gene-edited CAR T cells at clinical scale.
Journal: Molecular therapy. Methods & clinical development
Published: October 27, 2020
Last Updated: 09/26/2026